Use in combination with gestagens (6S) - 5-methyl tetrahydrofolate for Therapy of endometriosis with simultaneous reduction of the side effects of therapy, as well as reducing the risk of congenital Malformations at the beginning of pregnancy

摘要

Gestagens used antiandrogen Unit at a maximum Daily Dose equivalent to double the dose inhibition of ovulation in combination with (6) - 5-methyl tetrahydrofolate to obtain Pharmaceutical preparations for the treatment of endometriosis with simultaneous reduction of the EFE Ctos Therapeutic Side,Such as the negative influence on bone density and Bone Metabolism and the risk of Osteoporosis. In the case of initiated a Pregnancy, reducing the risk of congenital Malformations, including Neural tube defects, cleft palate, Lips and jaw, and pregnancy complications, such as placenta desprencimiento and Abortion.